# ARHGEF5

## Overview
ARHGEF5 is a gene that encodes the protein Rho guanine nucleotide exchange factor 5, which is a member of the Rho GEF family. This protein plays a pivotal role in the regulation of Rho-family GTPases, which are critical molecular switches involved in various cellular signal transduction pathways. These pathways govern essential cellular processes such as proliferation, differentiation, and motility (Huang2015Targeting). The ARHGEF5 protein is characterized by its Dbl homology (DH) domain, pleckstrin homology (PH) domain, and Src homology 3 (SH3) domain, which are integral to its function in guanine nucleotide exchange and interaction with other proteins (Fu2019Exploring; Bernadzki2020Arhgef5). Through its interactions and regulatory mechanisms, ARHGEF5 influences cell morphology and motility, and its dysregulation has been implicated in various pathological conditions, including cancer (HE2013Coexpression; Debily2003Expression).

## Structure
The ARHGEF5 protein, also known as Rho guanine nucleotide exchange factor 5, has a typical domain structure characteristic of Rho GEFs. It includes a Dbl homology (DH) domain, a pleckstrin homology (PH) domain, and a Src homology 3 (SH3) domain (Fu2019Exploring; Bernadzki2020Arhgef5). The SH3 domain interacts with a proline-rich region characterized by a PxxP motif, which is crucial for its auto-inhibitory function (Fu2019Exploring). This interaction stabilizes the auto-inhibitory state by occluding the DH domain, and the auto-inhibition can be relieved by targeting the SH3 domain with designed peptide ligands (Fu2019Exploring).

ARHGEF5 also has an N-terminal domain with several proline-rich motifs, although a shorter isoform called TIM lacks this N-terminal domain (Bernadzki2020Arhgef5). The TIM isoform consists of 519 C-terminal residues and retains the DH, PH, and SH3 domains (Fu2019Exploring). The C-terminal domain of ARHGEF5 is responsible for binding to the phosphorylated form of α-dystrobrevin 1 at tyrosine 713, indicating a post-translational modification involving phosphorylation (Bernadzki2020Arhgef5). The protein is localized to acetylcholine receptor-rich domains of the neuromuscular junction, suggesting its role in synaptic regions (Bernadzki2020Arhgef5).

## Function
ARHGEF5, also known as Rho guanine nucleotide exchange factor 5, is a protein that plays a crucial role in the regulation of Rho-family GTPases, which are molecular switches controlling various signal transduction pathways in eukaryotic cells. These pathways are essential for regulating diverse cellular behaviors such as proliferation, differentiation, and movement (Huang2015Targeting). ARHGEF5 facilitates the exchange of GDP for GTP on Rho GTPases, thereby activating them. This activation is critical for processes like cell adhesion, migration, and extracellular matrix remodeling. The protein is involved in Src-induced podosome formation, which is important for cell movement and invasion (Huang2015Targeting).

Structurally, ARHGEF5 contains a Dbl homology (DH) domain responsible for guanine nucleotide exchange and a Pleckstrin homology (PH) domain that targets the GEF to the plasma membrane and/or regulates nucleotide exchange. It also has an auto-inhibitory mechanism involving a helix N-terminal to the DH domain, stabilized by intramolecular interactions with a poly-proline sequence and an SH3 domain. This auto-inhibition is a common feature among RhoGEF family members, allowing for regulation of their catalytic activity (Huang2015Targeting). ARHGEF5 is primarily active in the cytoplasm, where it influences cell morphology and motility through its role in signaling pathways (HE2013Coexpression).

## Clinical Significance
Mutations and alterations in the expression of the ARHGEF5 gene have been implicated in various cancers. In breast cancer, ARHGEF5 is associated with tumorigenesis and metastasis. The gene is located near a common fragile site, FRA7I, and is often rearranged in breast carcinoma cells. Five novel alternative transcripts of ARHGEF5, lacking exons coding for the catalytic Dbl-homology domain, have been identified in aggressive breast tumors. These variants are linked to changes in the actin cytoskeleton and activation of Rac1, Cdc42, or RhoG, suggesting a role in breast cancer progression (Debily2003Expression).

In non-small cell lung cancer (NSCLC), ARHGEF5 is overexpressed and its co-expression with Src is associated with poor prognosis. This co-expression correlates with higher tumor stages and poor differentiation, indicating a role in tumor invasiveness and metastasis (HE2013Coexpression).

ARHGEF5 is also involved in endothelial permeability, where its loss enhances the barrier-disruptive effects of thrombin, suggesting a role in maintaining endothelial integrity and potentially impacting conditions like edema and inflammation (AmadoAzevedo2018A).

## Interactions
ARHGEF5, a Rho guanine nucleotide exchange factor, participates in several significant protein interactions that influence cellular processes. It forms a ternary complex with Src and phosphoinositide 3-kinase (PI3K), which is crucial for Src-induced podosome formation. This complex formation is enhanced by Src activation and is independent of the pleckstrin homology (PH) domain of ARHGEF5, indicating that phosphoinositide accumulation is not required for this interaction (Kuroiwa2011The).

ARHGEF5 also interacts with the Src SH3 domain, which is essential for its role in podosome formation. This interaction leads to the tyrosine phosphorylation of ARHGEF5, enhancing Src activity through a positive-feedback mechanism (Kuroiwa2011The). Additionally, ARHGEF5 binds to Gβγ subunits, which are involved in chemoattractant signaling, and this interaction enhances the activation of RhoA by ARHGEF5 (Wang2009Regulation).

In the neuromuscular junction, ARHGEF5 interacts with α-dystrobrevin 1 (aDB1) in a phospho-dependent manner, specifically at Tyr-713. This interaction is important for maintaining neuromuscular junction integrity by regulating actin dynamics (Bernadzki2020Arhgef5).


## References


[1. (Bernadzki2020Arhgef5) Krzysztof M. Bernadzki, Patrycja Daszczuk, Katarzyna O. Rojek, Marcin Pęziński, Marta Gawor, Bhola S. Pradhan, Teresa de Cicco, Monika Bijata, Krystian Bijata, Jakub Włodarczyk, Tomasz J. Prószyński, and Paweł Niewiadomski. Arhgef5 binds α-dystrobrevin 1 and regulates neuromuscular junction integrity. Frontiers in Molecular Neuroscience, June 2020. URL: http://dx.doi.org/10.3389/fnmol.2020.00104, doi:10.3389/fnmol.2020.00104. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnmol.2020.00104)

[2. (AmadoAzevedo2018A) Joana Amado-Azevedo, Renee X. de Menezes, Geerten P. van Nieuw Amerongen, Victor W. M. van Hinsbergh, and Peter L. Hordijk. A functional sirna screen identifies rhogtpase-associated genes involved in thrombin-induced endothelial permeability. PLOS ONE, 13(7):e0201231, July 2018. URL: http://dx.doi.org/10.1371/journal.pone.0201231, doi:10.1371/journal.pone.0201231. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0201231)

[3. (HE2013Coexpression) PING HE, WEI WU, HAIDONG WANG, KELONG LIAO, WEI ZHANG, GANG XIONG, FENG WU, GANG MENG, and KANG YANG. Co-expression of rho guanine nucleotide exchange factor 5 and src associates with poor prognosis of patients with resected non-small cell lung cancer. Oncology Reports, 30(6):2864–2870, October 2013. URL: http://dx.doi.org/10.3892/or.2013.2797, doi:10.3892/or.2013.2797. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/or.2013.2797)

[4. (Kuroiwa2011The) Miho Kuroiwa, Chitose Oneyama, Shigeyuki Nada, and Masato Okada. The guanine nucleotide exchange factor arhgef5 plays crucial roles in src-induced podosome formation. Journal of Cell Science, 124(10):1726–1738, May 2011. URL: http://dx.doi.org/10.1242/jcs.080291, doi:10.1242/jcs.080291. This article has 51 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1242/jcs.080291)

[5. (Huang2015Targeting) Ou Huang, Dandan Wu, Feiyan Xie, Lili Lin, Xiaobo Wang, Min Jiang, Yafen Li, Weiguo Chen, Kunwei Shen, and Xiaoqu Hu. Targeting rho guanine nucleotide exchange factor arhgef5/tim with auto-inhibitory peptides in human breast cancer. Amino Acids, 47(6):1239–1246, March 2015. URL: http://dx.doi.org/10.1007/s00726-015-1950-0, doi:10.1007/s00726-015-1950-0. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00726-015-1950-0)

[6. (Debily2003Expression) M.-A. Debily. Expression and molecular characterization of alternative transcripts of the arhgef5/tim oncogene specific for human breast cancer. Human Molecular Genetics, 13(3):323–334, December 2003. URL: http://dx.doi.org/10.1093/hmg/ddh024, doi:10.1093/hmg/ddh024. This article has 35 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddh024)

[7. (Wang2009Regulation) Zhenglong Wang, Yosuke Kumamoto, Ping Wang, Xiaoqing Gan, David Lehmann, Alan V. Smrcka, Lauren Cohn, Akiko Iwasaki, Lin Li, and Dianqing Wu. Regulation of immature dendritic cell migration by rhoa guanine nucleotide exchange factor arhgef5. Journal of Biological Chemistry, 284(42):28599–28606, October 2009. URL: http://dx.doi.org/10.1074/jbc.m109.047282, doi:10.1074/jbc.m109.047282. This article has 41 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m109.047282)

[8. (Fu2019Exploring) Yong Fu, Ping He, Yu Zhou, Shengyuan Huang, Lin Liang, and Shengchun Liu. Exploring the systematic effect of n‐substituted pxxp motifs on peptoid affinity to arhgef5/tim sh3 domain and its relationship with arhgef5/tim activation. Proteins: Structure, Function, and Bioinformatics, 87(11):979–991, June 2019. URL: http://dx.doi.org/10.1002/prot.25760, doi:10.1002/prot.25760. This article has 4 citations.](https://doi.org/10.1002/prot.25760)